NxStage Medical (NSDQ:NXTM) touted FDA clearance for high flow capabilities for the company’s System One home hemodialysis technology, a device the company calls the "only truly portable hemodialysis system cleared for home use."
The Lawrence, Mass.-based medical device maker plans to launch new higher flow System One devices later this year, according to a press release.